Dear Colleagues
The treatment of Tuberculosis is increasingly becoming a challenge world wide and all around the experts in the field are involved in intensive research to be able to cope with the various concerns with regard to treatment.
The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and having them present and discuss the latest important scientific findings in the TB clinical pharmacology field.
Additionally, scientific, regulatory or strategy issues that are highly relevant to the optimization of TB treatment will be exchanged and discussed.
The format of the meeting will be a one-day workshop consisting of invited lectures, abstract presentations, roundtable discussions and poster sessions. Much time will be allocated to questions & answers and discussion in order to set up an intimate interactive workshop.
Topics that will be addressed include biopharmaceatics, pharmacokinetics & pharmacodynamics of TB drugs, adverse effects of TB treatment and the treatment of TB and HIV simultaneously.
This meeting is just prior to the TB-TC meeting and the congress of the American Thoracic Society (ATS), in Toronto.
The aim of this abstract-driven workshop is to make a significant contribution to the optimization of TB treatment, by bringing experts together and having them present and discuss the latest important scientific findings in the TB clinical pharmacology field.
Additionally, scientific, regulatory or strategy issues that are highly relevant to the optimization of TB treatment will be exchanged and discussed.
The format of the meeting will be a one-day workshop consisting of invited lectures, abstract presentations, roundtable discussions and poster sessions. Much time will be allocated to questions & answers and discussion in order to set up an intimate interactive workshop.
Topics that will be addressed include biopharmaceatics, pharmacokinetics & pharmacodynamics of TB drugs, adverse effects of TB treatment and the treatment of TB and HIV simultaneously.
This meeting is just prior to the TB-TC meeting and the congress of the American Thoracic Society (ATS), in Toronto.
